Design of trials with composite endpoints with the R package compAREdesign

Composite endpoints are widely used as primary endpoints in clinical trials. Designing trials with time-to-event endpoints can be particularly challenging because the proportional hazard assumption usually does not hold when using a composite endpoint, even when the premise remains true for their co...

Descripción completa

Detalles Bibliográficos
Autores: Cortés Martínez, Jordi|||0000-0002-3764-0795, Bofill Roig, Marta|||0000-0002-4400-7541, Gómez Melis, Guadalupe|||0000-0003-4252-4884
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Politècnica de Catalunya (UPC)
Repositorio:UPCommons. Portal del coneixement obert de la UPC
Idioma:inglés
OAI Identifier:oai:upcommons.upc.edu:2117/377308
Acceso en línea:https://hdl.handle.net/2117/377308
https://dx.doi.org/10.48550/arXiv.2211.02535
Access Level:acceso abierto
Palabra clave:Biometry
Statistics
Pharmaceutical technology
Composite endpoints
Clinical trial
Study design
ARE
Biometria
Estadística
Tecnologia farmacèutica
Àrees temàtiques de la UPC::Matemàtiques i estadística::Estadística matemàtica
Descripción
Sumario:Composite endpoints are widely used as primary endpoints in clinical trials. Designing trials with time-to-event endpoints can be particularly challenging because the proportional hazard assumption usually does not hold when using a composite endpoint, even when the premise remains true for their components. Consequently, the conventional formulae for sample size calculation do not longer apply. We present the R package CompAREdesign by means of which the key elements of trial designs, such as the sample size and effect sizes, can be computed based on the information on the composite endpoint components. CompAREdesign provides the functions to assess the sensitivity and robustness of design calculations to variations in initial values and assumptions. Furthermore, we describe other features of the package, such as functions for the design of trials with binary composite endpoints, and functions to simulate trials with composite endpoints under a wide range of scenarios.